Literature DB >> 19415569

Prevalence and correlates of infection with human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among drug users in Italy: a cross-sectional study.

Laura Camoni1, Vincenza Regine, Maria C Salfa, Giovanni Nicoletti, Pietro Canuzzi, Natalia Magliocchetti, Giovanni Rezza, Barbara Suligoi.   

Abstract

Drug users in Italy continue to have a high prevalence of infection with the human immunodeficiency virus and hepatitis B and C viruses, associated with older age, being unemployed, injecting use, and a longer history of injecting. The results underline the need for control programmes among drug users in Italy.

Entities:  

Mesh:

Year:  2009        PMID: 19415569     DOI: 10.1080/00365540902946528

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  3 in total

1.  Incidence and Risk Factors for Hepatitis C Virus Infection among Illicit Drug Users in Italy.

Authors:  Enea Spada; Giovanni Rezza; Anna Rosa Garbuglia; Flavia Lucia Lombardo; Ornella Zuccaro; Francesca Menniti Ippolito; Elisabetta Cupellaro; Stefania Capone; Maria Rosaria Capobianchi; Alfredo Nicosia; Riccardo Cortese; Antonella Folgori; Alfonso Mele
Journal:  J Urban Health       Date:  2018-02       Impact factor: 3.671

2.  Hepatitis C prevalence in injecting drug users in Europe, 1990-2007: impact of study recruitment setting.

Authors:  M Rondy; L Wiessing; S J Hutchinson; C Matheï; F Mathis; V Mravcik; L Norden; M Rosińska; O Scutelniciuc; B Suligoi; F Vallejo; M VAN Veen; M Kretzschmar
Journal:  Epidemiol Infect       Date:  2012-05-17       Impact factor: 4.434

3.  HIV seroprevalence in five key populations in Europe: a systematic literature review, 2009 to 2019.

Authors:  Annemarie Rinder Stengaard; Lauren Combs; Virginie Supervie; Sara Croxford; Sarika Desai; Ann K Sullivan; Stine Finne Jakobsen; Quenia Santos; Daniel Simões; Jordi Casabona; Jeffrey V Lazarus; John B F de Wit; Frank M Amort; Anastasia Pharris; Lina Nerlander; Dorthe Raben
Journal:  Euro Surveill       Date:  2021-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.